Detalhe da pesquisa
1.
Subcutaneous Administration of a Monoclonal Antibody to Prevent Malaria.
N Engl J Med
; 390(17): 1549-1559, 2024 May 02.
Artigo
Inglês
| MEDLINE | ID: mdl-38669354
2.
Low-Dose Subcutaneous or Intravenous Monoclonal Antibody to Prevent Malaria.
N Engl J Med
; 387(5): 397-407, 2022 08 04.
Artigo
Inglês
| MEDLINE | ID: mdl-35921449
3.
United States regulatory requirements for skin and eye irritation testing.
Cutan Ocul Toxicol
; 38(2): 141-155, 2019 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-30418044
4.
Micro-CT imaging: Developing criteria for examining fetal skeletons in regulatory developmental toxicology studies - A workshop report.
Regul Toxicol Pharmacol
; 77: 100-8, 2016 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-26930635
5.
Low-dose intravenous and subcutaneous CIS43LS monoclonal antibody for protection against malaria (VRC 612 Part C): a phase 1, adaptive trial.
Lancet Infect Dis
; 23(5): 578-588, 2023 05.
Artigo
Inglês
| MEDLINE | ID: mdl-36708738
6.
Mechanism of action and development of selective aryl hydrocarbon receptor modulators for treatment of hormone-dependent cancers (Review).
Int J Oncol
; 20(6): 1123-8, 2002 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-12011988
7.
U.S. Food and Drug Administration approval: ofatumumab for the treatment of patients with chronic lymphocytic leukemia refractory to fludarabine and alemtuzumab.
Clin Cancer Res
; 16(17): 4331-8, 2010 Sep 01.
Artigo
Inglês
| MEDLINE | ID: mdl-20601446
8.
Estrogen regulation of c-fos gene expression through phosphatidylinositol-3-kinase-dependent activation of serum response factor in MCF-7 breast cancer cells.
Biochem Biophys Res Commun
; 294(2): 384-94, 2002 Jun 07.
Artigo
Inglês
| MEDLINE | ID: mdl-12051724